Skip to main content
. 2024 Apr 14;16(2):e12582. doi: 10.1002/dad2.12582

TABLE 3.

General linear model results predicting cognitive skills and functional abilities in adults with DS prior to dementia, n = 260.

β Estimate [95% CI]
mCRT a VMI Block Design Vineland‐3 ABC
Site (vs. site 1)
Site 2 0.279 [−0.188, 0.746] −1.603 [−3.236, 0.030] −5.227 ** [−10.083, −0.370] −11.568 ** [−19.033, −4.103]
Site 3 0.048 [−0.388, 0.485] −0.604 [−2.131, 0.922] −0.540 [−5.078, 3.999] −12.463 ** [−19.439, −5.487]
Site 4 0.842 ** [0.438, 1.246] −1.757 [−3.169, −0.344] −7.332 ** [−11.533, −3.131] −4.451 [−10.908, 2.007]
Site 5 0.793 [−0.506, 2.092] −0.281 [−4.827, 4.265] 3.357 [−10.162, 16.877] 8.097 [−12.682, 28.876]
Site 6 0.132 [−0.271, 0.535] −0.686 [−2.096, 0.723] 0.119 [−4.073, 4.311] 0.879 [−5.564, 7.322]
Site 7 −0.003 [−0.365, 0.359] 0.283 [−0.984, 1.549] −1.466 [−5.233, 2.301] −1.480 [−7.270, 4.310]
Age 0.042 ** [0.027, 0.057] −0.072 ** [−0.126, −0.019] −0.147 [−0.307, 0.013] −0.383 ** [−0.628, −0.137]
Lifetime ID level (vs. mild)
Moderate 0.405 ** [0.164, 0.647] −1.732 ** [−2.576, −0.887] −6.590 ** [−9.101, −4.078] −16.127 ** [−19.987, −12.267]
Severe/profound 1.081 ** [0.663, 1.498] −4.280 ** [−5.741, −2.820] −15.994 ** [−20.337, −11.650] −28.125 ** [−34.802, −21.449]
Biological sex (vs. male) −0.236 * [−0.465, −0.008] −0.316 [−1.114, 0.482] −1.760 [−4.134, 0.614] 0.558 [−3.091, 4.207]
Plasma Aβ42/40 7.339 [−18.406, 33.085] 57.615 [−32.458, 147.689] 280.604 * [12.726, 548.482] 122.718 [−289.009, 534.444]
Site (vs. site 1)
Site 2 0.268 [−0.187, 0.724] −1.567 [−3.212, 0.078] −5.452 ** [−10.354, −0.549] −12.400 ** [−20.115, −4.685]
Site 3 0.091 [−0.331, 0.513] −0.743 [−2.267, 0.781] −2.185 [−6.726, 2.356] −13.148 ** [−20.294, −6.001]
Site 4 0.824 ** [0.430, 1.218] −1.798 [−3.221, −0.375] −7.643 ** [−11.883, −3.403] −4.680 [−11.352, 1.992]
Site 5 0.996 [−0.276, 2.269] −0.269 [−4.863, 4.325] 3.731 [−9.961, 17.422] 8.126 [−13.419, 29.670]
Site 6 0.151 [−0.254, 0.557] ‐0.827 [−2.291, 0.637] 0.223 [−4.140, 4.586] 0.761 [−6.104, 7.627]
Site 7 0.027 [−0.327, 0.381] 0.200 [−1.077, 1.477] −1.803 [−5.609, 2.003] −1.672 [−7.661, 4.317]
Age 0.038 ** [0.023, 0.053] −0.077 ** [−0.131, −0.024] −0.136 [−0.296, 0.024] −0.289 * [−0.541, −0.038]
Lifetime ID level (vs. mild)
Moderate 0.378 ** [0.141, 0.614] −1.777 ** [−2.630, −0.923] −6.507 ** [−9.051, −3.964] −15.185 ** [−19.187, −11.183]
Severe/profound 0.983 ** [0.572, 1.395] −4.154 ** [−5.640, −2.668] −15.491 ** [−19.919, −11.063] −27.074 ** [−34.042, −20.107]
Biological sex (vs. male) −0.284 * [−0.511, −0.058] −0.247 [−1.065, 0.570] −1.578 [−4.014, 0.858] 0.596 [−3.238, 4.430]
Plasma total tau 0.271 ** [0.125, 0.417] −0.102 [−0.631, 0.427] −0.559 [−2.135, 1.016] −1.673 [−4.152, 0.806]
Site (vs. site 1)
Site 2 0.263 [−0.201, 0.728] −1.651 * [−3.276, −0.026] −5.211 ** [−10.045, −0.377] −13.454 ** [−21.231, −5.677]
Site 3 −0.034 [−0.465, 0.397] −0.562 [−2.070, 0.947] −0.724 [−5.211, 3.764] −13.377 ** [−20.597, −6.157]
Site 4 0.781 ** [0.377, 1.185] −1.857 * [−3.269, −0.444] −6.953 ** [−11.155, −2.751] −5.702 [−12.463, 1.058]
Site 5 0.497 [−0.810, 1.805] 0.072 [−4.501, 4.645] 8.885 [−4.717, 22.487] 7.738 [−14.146, 29.622]
Site 6 0.109 [−0.290, 0.508] −0.730 [−2.127, 0.667] 0.242 [−3.912, 4.397] 0.244 [−6.440, 6.928]
Site 7 −0.038 [−0.399, 0.322] 0.320 [−0.941, 1.581] −1.020 [−4.770, 2.731] −2.162 [−8.196, 3.872]
Age 0.031 ** [0.013, 0.049] −0.065 * [−0.128, −0.001] 0.023 [−0.165, 0.212] −0.318 * [−0.622, −0.015]
Lifetime ID level (vs. mild)
Moderate 0.373 ** [0.135, 0.610] −1.704 ** [−2.535, −0.874] −6.332 ** [−8.802, −3.862] −15.358 ** [−19.332, −11.383]
Severe/profound 1.041 ** [0.629, 1.452] −4.190 ** [−5.630, −2.750] −14.967 ** [−19.250, −10.685] −27.989 ** [−34.879, −21.099]
Biological sex (vs. male) −0.238 * [−0.465, −0.011] −0.259 [−1.053, 0.534] −1.449 [−3.808, 0.911] 0.411 [−3.385, 4.207]
Plasma NfL 0.015 * [0.001, 0.028] −0.012 [−0.060, 0.036] −0.228 ** [−0.371, −0.086] 0.047 [−0.182, 0.277]

Abbreviations: ABC, Adaptive Behavior Composite; Aβ, amyloid beta; CI, confidence interval; DS, Down syndrome; ID, intellectual disability; mCRT, modified Cued Recall Test; NfL, neurofilament light chain.

*

< 0.05.

**

P < 0.01.

a

Reversed natural log transformation, positive coefficient means an inverse relationship.